Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Completed · Phase 2

Conditions studied: Malignant Mesothelioma

In brief

RATIONALE: Patient abstract not available PURPOSE: Patient abstract not available

Key facts

Study ID

NCT00004033

Run by

NYU Langone Health

People needed

30

Starts

1998-09-01

Last updated by the study team

2011-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.